2022
DOI: 10.3390/diagnostics12112805
|View full text |Cite
|
Sign up to set email alerts
|

Efficient Tracing of the SARS-CoV-2 Omicron Variants in Santa Barbara County Using a Rapid Quantitative Reverse Transcription PCR Assay

Abstract: The emergence of the SARS-CoV-2 Omicron variant in 2021 is associated with a global surge of cases in late 2021 and early 2022. Identifying the introduction of novel SARS-CoV-2 variants to a population is imperative to inform decisions by clinicians and public health officials. Here, we describe a quantitative reverse transcription PCR-based assay (RT-qPCR) targeting unique mutations in the Omicron BA.1/BA1.1 and BA.2 viral genomes. This assay accurately and precisely detect the presence of these Omicron varia… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 40 publications
0
2
0
Order By: Relevance
“…Despite this limitation, we showed that all probes were specific for their cognate sequences and to independently confirm the SNP calling, regions harbouring respective mutation in the S -gene were amplified and Sanger sequenced. Other studies have used either Sanger sequencing or WGS for confirmation ( Erster et al., 2021 ; Aralis et al., 2022 ; Moisan et al., 2023 ; Spiess et al., 2023 ; Zare Ashrafi et al., 2023 ). A large proportion of samples, particularly from Clinical Site 2, could not be confirmed as PCR failed to generate amplicons for sequencing.…”
Section: Discussionmentioning
confidence: 99%
“…Despite this limitation, we showed that all probes were specific for their cognate sequences and to independently confirm the SNP calling, regions harbouring respective mutation in the S -gene were amplified and Sanger sequenced. Other studies have used either Sanger sequencing or WGS for confirmation ( Erster et al., 2021 ; Aralis et al., 2022 ; Moisan et al., 2023 ; Spiess et al., 2023 ; Zare Ashrafi et al., 2023 ). A large proportion of samples, particularly from Clinical Site 2, could not be confirmed as PCR failed to generate amplicons for sequencing.…”
Section: Discussionmentioning
confidence: 99%
“…Most studies in the published literature describing rRT-PCR assays that identify Omicron lineages are only capable of differentiating the original Omicron lineage (B.1.1.529, equivalent to BA.1) from other VOCs or BA.1 from BA.2 15 , 44 49 . Few studies have been published which describe rRT-PCR assays that detect and distinguish between BA.1, BA.2, BA.4, and BA.5.…”
Section: Discussionmentioning
confidence: 99%